Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
Arantxa Valdivia, Ignacio Torres, Víctor Latorre, Clara Francés-Gómez, Eliseo Albert, Roberto Gozalbo-Rovira, María Jesús Alcaraz, Javier Buesa, Jesús Rodríguez-Díaz, Ron Geller, David Navarro
doi: https://doi.org/10.1101/2020.09.07.20188151
Arantxa Valdivia
aMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Ignacio Torres
aMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Víctor Latorre
bInstitute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain.
Clara Francés-Gómez
bInstitute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain.
Eliseo Albert
aMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Roberto Gozalbo-Rovira
cDepartment of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
María Jesús Alcaraz
aMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Javier Buesa
aMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
cDepartment of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
Jesús Rodríguez-Díaz
cDepartment of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
Ron Geller
bInstitute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain.
David Navarro
aMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
cDepartment of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
Data Availability
Raw data were generated at Hospital Clinico Valencia. Derived data supporting the finding of this study are available from the corresponding author on request
Posted September 09, 2020.
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
Arantxa Valdivia, Ignacio Torres, Víctor Latorre, Clara Francés-Gómez, Eliseo Albert, Roberto Gozalbo-Rovira, María Jesús Alcaraz, Javier Buesa, Jesús Rodríguez-Díaz, Ron Geller, David Navarro
medRxiv 2020.09.07.20188151; doi: https://doi.org/10.1101/2020.09.07.20188151
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
Arantxa Valdivia, Ignacio Torres, Víctor Latorre, Clara Francés-Gómez, Eliseo Albert, Roberto Gozalbo-Rovira, María Jesús Alcaraz, Javier Buesa, Jesús Rodríguez-Díaz, Ron Geller, David Navarro
medRxiv 2020.09.07.20188151; doi: https://doi.org/10.1101/2020.09.07.20188151
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)